Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Surgery. 2019 Mar 21;165(6):1193–1198. doi: 10.1016/j.surg.2019.02.005

Table 2.

Unadjusted outcomes

Transabdominal resection Local excision
Neoadjuvant chemoradiation none Neoadjuvant chemoradiation none p-value
(n=1,761) (n=6,629) (n=695) (n=2,936)
30 day mortality 0.7% (12) 1.3% (86) 0.7% (5) 0.7% (20) < 0.001
90 day mortality 1.6% (29) 2.7% (176) 1.4% (10) 2.1% (62) < 0.001
1 year survival* 96.6% (1,681) 94.9% (6,128) 97.5% (665) 93.2% (2,654) -
2 year survival* 92.6% (1,498) 90.8% (5,427) 92.2% (589) 87.2% (2,330) -
5 year survival* 79.6% (827) 75.1% (2,817) 77.7% (288) 67.6% (1,207) -
*

from Kaplan-Meier analysis, censored for lack of event occurrence